Results 181 to 189 of about 4,485 (189)

Bioactive Compounds from Euphorbia usambarica Pax. with HIV-1 Latency Reversal Activity

Pharmaceuticals, 2021
Racheal Nell, Andrea Vasas, Judit Höhmann   +2 more
exaly  

Romidepsin reverses HIV-1 latency in vivo

AIDS, 2016
openaire   +2 more sources

HIV latency reversal agents: A potential path for functional cure?

European Journal of Medicinal Chemistry, 2021
Jean Leandro Dos Santos, Juliana Romano Lopes, Chiba Diego EIDY   +2 more
exaly  

Isoform-Selective Versus Nonselective Histone Deacetylase Inhibitors in HIV Latency Reversal

AIDS Research and Human Retroviruses, 2022
Evelyn Yayra Bonney, George Kyei
exaly  

Potentiation of Drug Toxicity through Virus Latency Reversal Promotes Preferential Elimination of HIV Infected Cells

Advanced Therapeutics, 2022
Alexander Zelikin
exaly  

Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo

Journal of Virology, 2018
, Carolina Garrido, Guido Ferrari
exaly  

Tracking HIV Rebound following Latency Reversal Using Barcoded HIV

Cell Reports Medicine, 2020
Jérôme Zack, Paul Wender, Jocelyn T Kim   +2 more
exaly  

Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1

EBioMedicine, 2019
Robbie Mailliard, Tatiana Garcia-Bates, Charles R Rinaldo   +2 more
exaly  

Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets

Antimicrobial Agents and Chemotherapy
, Nancie Archin, Ellen Van Gulck
exaly